Caffeine combined with excitatory neuromodulation based on transcranial Direct Current Stimulation (tDCS) enhances performance in a time-trial CrossFit® workout: a randomized, placebo-controlled, double-blind study

dc.creatorSá Filho, Alberto Souza de
dc.creatorSilva, Thiago Albernaz
dc.creatorInacio, Pedro Augusto Querido
dc.creatorFernandes, Vicente Aprigliano
dc.creatorSilva, Iransé Oliveira
dc.creatorChiappa, Gaspar Rogério da Silva
dc.creatorVieira, Rodolfo de Paula
dc.creatorAguiar, Antônio Sérgio Nakao de
dc.creatorCunha, Raphael Martins
dc.creatorFajemiroy, James Oluwagbamigbe
dc.date.accessioned2025-11-14T11:47:46Z
dc.date.available2025-11-14T11:47:46Z
dc.date.issued2025
dc.description.abstractBackground: Caffeine (CAF) and transcranial direct current stimulation (tDCS) are ergogenic strategies with potential benefits for performance, yet their combined effects remain underexplored, particularly in high-intensity functional training contexts such as CrossFit®. Objective: This randomized, double-blind, placebo-controlled crossover study aimed to investigate the impact of tDCS, with and without CAF, on performance time in the Clean & Jerk (C&J) during the benchmark WOD GRACE among competitive CrossFit® athletes. Secondarily, we aimed to compare the RPE across the different experimental conditions, as well as to establish the relationship between personal record (PR) values adjusted for body mass and the execution time of the WOD GRACE, considering different athletes’ classification levels (RX Elite and RX Intermediate). Methods: Twenty participants completed four experimental conditions: CAF ingestion (400 mg) combined with anodal tDCS (CAF + a-tDCS), CAF with Sham tDCS (CAF + Sham-tDCS), placebo (PLA) with a-tDCS (PLA + a-tDCS), and PLA with Sham tDCS (PLA + Sham-tDCS). Results: The results indicated that the combination of CAF + a-tDCS significantly improved performance, reducing execution time (205.5 ± 58.0 s) compared to CAF + Sham-tDCS (218.3 ± 61.2 s; p = 0.034), PLA + a-tDCS (231.7 ± 64.1 s; p = 0.012), and PLA + Sham-tDCS (240.9 ± 66.4 s; p = 0.002). However, no significant differences were observed between CAF + Sham-tDCS and PLA + a-tDCS (p = 0.690), CAF + Sham-tDCS and PLA + Sham-tDCS (p = 0.352), or PLA + a-tDCS and PLA + Sham-tDCS (p = 0.595). The responder analysis revealed that 45% of participants improved performance with isolated tDCS, while 60% responded positively to CAF. No significant differences were found in RPE scores among conditions (p = 0.145). Additionally, no correlations were identified between PR values adjusted for body mass and execution time in both RX Elite (r = 0.265; p = 0.526) and RX Intermediate (r = 0.049; p = 0.901) groups, nor between training experience and performance across interventions. Conclusions: These findings suggest that tDCS, when combined with CAF, may serve as an effective ergogenic aid for improving performance in high-intensity functional training, whereas its isolated use does not yield meaningful benefits.
dc.identifier.citationSÁ FILHO, Alberto Souza et al. Caffeine combined with excitatory neuromodulation based on transcranial Direct Current Stimulation (tDCS) enhances performance in a time-trial CrossFit® workout: a randomized, placebo-controlled, double-blind study. Nutrients, Basel, v. 17, n. 7, e1261, 2025. DOI: 10.3390/nu17071261. Disponível em: https://www.mdpi.com/2072-6643/17/7/1261. Acesso em: 13 nov. 2025.
dc.identifier.doi10.3390/nu17071261
dc.identifier.issne- 2072-6643
dc.identifier.urihttps://repositorio.bc.ufg.br//handle/ri/29075
dc.language.isoeng
dc.publisher.countrySuica
dc.publisher.departmentInstituto de Ciências Biológicas - ICB (RMG)
dc.rightsAcesso Aberto
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjecttDCS
dc.subjectPerformance
dc.subjectHIFT
dc.subjectHIIT
dc.subjectHigh-intensity functional training
dc.subjectCrossFit®
dc.titleCaffeine combined with excitatory neuromodulation based on transcranial Direct Current Stimulation (tDCS) enhances performance in a time-trial CrossFit® workout: a randomized, placebo-controlled, double-blind study
dc.typeArtigo

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Artigo - Alberto Souza de Sá Filho - 2025.pdf
Tamanho:
9.59 MB
Formato:
Adobe Portable Document Format

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: